SlidesetRSVHIVHost-microbiome interactions at the oral mucosal barrier - Niki Moutsopoulos, DDS, PhDView Slideset
SlidesetRSVHIVRegulation of intestinal viral infections by the microbiota - Megan Baldridge, MD, PhDView Slideset
SlidesetRSVHIVGlycomic Determinants of Gut Microbial Dysbiosis and Translocation During Suppressed HIV Infection - Leila GironView Slideset
SlidesetRSVHIVHost Genetic Determinants of the Vaginal Microbiome and Bacterial Vaginosis in Kenyan Women - Supriya MehtaView Slideset
SlidesetRSVHIVELEVATED FECAL INFLAMMATORY BIOMARKERS IN HIV-/+ MSM ASSOCIATE WITH GUT MICROBIOTA - Jennifer SchneiderView Slideset
SlidesetRSVHIVMetaproteomics to understand mucosal inflammation associated with HIV acquisition risk in young African women - Lindi MassonView Slideset
SlidesetRSVHIVUpdate on live biotherapeutic trials to prevent vaginal dysbiosis and HIV - Craig Cohen, MD, MPHView Slideset
SlidesetRSVHIVOral Fecal Microbiota Transplantation Increases Gut Microbiome Diversity and Alters the Microbiome Distribution in People with HIV - Netanya Utay, MDView Slideset
SlidesetRSVHIVThe relationship between the gut microbiome, inflammation and metabolic disease in HIV infected and high risk populations - Catherine LozuponeView Slideset
SlidesetRSVHIVEndotoxemia, inflammation and HIV: Revisiting an old concept - Jean-Pierre Routy, MDView Slideset
SlidesetRSVHIVDevelopment of a live biotherapeutic product: Opportunities and challenges - Scott Plevy, MDView Slideset